// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Coating Damage of Drug-Eluting Stent Occurs in Front Edge Strut: a Scanning Electron Microscopy Study

Aiko Shimokado - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Comparison of Long-Term Outcomes with Everolimus-Eluting- and Sirolimus-Eluting Stents in Small Coronary Artery Disease

Hironori Kitabata - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Percutaneous Coronary Intervention In A Complex Patient Population: A Comparison of First- Versus Second-Generation Drug-Eluting Stent use on In-Hospital and 1-Year Outcomes

Joshua Loh - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

TAXUS

What Is The Optimal Revascularization Strategy For Percutaneous Coronary Intervention Of Distal Anastomotic Lesions After Coronary Bypass Surgery?

Salem Badr - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ST-1

Drug-Eluting Stent Event Registry of Thrombosis (DESERT): The International Drug-Eluting Stent Thrombosis Registry, Angiographic Assessment

Ron Waksman - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Efficacy of Additional Ballooning with a Dual Wire Balloon After Rotational Atherectomy to Expand the Drug-Eluting Stent for Heavily Calcified Coronary Lesions

Ryuichi Kato - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Outcomes with Everolimus-Eluting Stent for the Treatment of Cardiac Allograft Vasculopathy

Babak Azarbal - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Three Year Follow up of a Randomized Comparison of Nobori, Biolimus A9 Eluting Stent(BES) with Cypher, Sirolimus Eluting Stent(SES) for Coronary Revascularization in Japanese Population

Takeshi Kimura - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent Versus Cobalt Chromium Everolimus-Eluting Stent

Ruogu Li - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Promus Element

Contemporary PCI Practices Across Three Continents: A Glimpse Into the Preliminary Results of e-NObori Study

Jawed Polad - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Crofelemer

Final Three Year Results Following Resolute Zotarolimus-Eluting Stent Implantation in the RESOLUTE International Trial

Franz-Josef Neumann - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels 2.5 mm Diameter

Ronald Caputo - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Very Late Stent Thrombosis is Associated with Lower Mortality than Early Stent Thrombosis: A Report from the VHA CART Program

Ehrin Armstrong - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison

Salvatore Cassese - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent

Shirish Hiremath - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program

Vasim Farooq - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Impact of the New BioMime Sirolimus-Eluting Stent in Comlex Patients of Daily Practice Preliminary Results of the MeriT-2 Study

Erlon de Abreu-Silva - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Feasibility and clinical outcomes of 38 mm long drug eluting stent treatment for diffuse coronary artery disease in Egyptian population

Mohamed Loutfi - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Assessment of endothelial function in patients randomly treated with a polymer-free sirolimus eluting stent and its bare-metal equivalent: results of the VESTASYNC II trial

Breno Almeida - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Comparison in the 5-year Outcome of Pericardium and Polytetrafluoroethylene-Covered Stents for Saphenous Vein Graft Lesions

Sandeep Basavarajaiah - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved